Document Type : original article


1 School of Medicine, children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

2 Pediatric department. Taleghani hospital. Abadan University of medical sciences. Abadan. Iran.

3 Pediatrician, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

4 Pediatric pulmonary disease and sleep medicine research Center. Pediatric Center of excellence. Children’s medical center. Tehran University of medical sciences. Tehran. Iran.

5 MD, Pediatrician.Emergency devision,Bahrami hospital,Tehran University of Medical Science,Tehran,Iran

6 Associate Professor of Pediatric Pulmonology, Mashhad University of Medical Sciences, Mashhad, Iran.

7 Mashhad University of Medical Sciences

8 MD, Pediatric Pulmonologist, Pediatric pulmonary Disease and sleep Medicine Research Center, Children’s medical center Hospital, Tehran University of medical sciences, Tehran, Iran


Background: Cystic fibrosis (CF) is an inherited disease which involves multiple organs including respiratory tract. It results in chronic respiratory signs and symptoms which exacerbate with frequent lung infections. The majority of exacerbations require hospitalization and intravenous antibiotic therapy as part of the management. The aim of this survey was to study the effectiveness of outpatient management of pulmonary exacerbations on pulmonary function tests.
Methods: This randomized clinical trial included all CF patients older than 6 years old who presented with a pulmonary exacerbation and were able to perform Spirometric tests. All eligible CF patients first referred to pulmonary function tests center to determine forced expiratory volume in the first second (FEV1), residual volume (RV), total lung capacity (TLC) and airway specific resistance (SRaw). Then, they were treated outpatiently for 2 to 4 weeks and after that, they underwent all the tests again; and the participants’ improvements in pulmonary function tests after outpatient treatment were investigated.
Result: In this study, 32 patients were enrolled including 13 women (40.6%) and 19 men (59.4%). Mean and standard deviation (SD) of pulmonary variable, before and after the treatment were investigated. All of them were statistically significant. Sub-analysis of data based on gender was also performed showing that outpatient treatment led to significant improvements in all of the variables except for the percentage of RV in females (p value = 0.08).
Conclusion: The findings revealed that outpatient management of CF exacerbations effectively improved values of FEV1, SRaw and TLC along with reducing RV values and air trapping. Thus, applying this method on appropriately selected CF patients, may prevent unnecessary hospitalization and subsequent disadvantages.


  1. Kliegman. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders; 2007.
  2. Hassanzad M, Ansari M, Valinejadi A, Sayedi SJ, Velayati AA. Cystic fibrosis patient’s evaluation in the last decades in a referral center, Tehran-Iran. International Journal of Pediatrics. 2019; 7(8):9997-10007.
  3. Brunson JM, Bridges D, Anderson R, Graves N, Schwann C. Cystic fibrosis diagnosed at age 45 based on symptoms of acute pancreatitis. InBaylor University Medical Center Proceedings 2009 Jan 1 (Vol. 22, No. 1, pp. 13-15). Taylor & Francis.
  4. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 2005; 39(4): 292-8.
  5. Sharma GD. Cystic Fibrosis (Online). 2012. (cited 2012 Apr 3); Available from: URL:
  6. Denis MS, Ramotar K, Vandemheen K, Tullis E, Ferris W, Chan F, Lee C, Slinger R, Aaron SD. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. Chest 2007; 131(4): 1188-1196.
  7. Bhatt JM1. Treatment of pulmonary exacerbations in cystic fibrosis. Eur Respir Rev. 2013 Sep 1; 22(129):205-16.
  8. Lukic KZ, Coates AL1, 2. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr Pulmonol. 2015 Sep; 50(9):863-8.
  9. Horck MV, Winkens B, Wesseling G, Vliet DV, Kant KVd, Vaassen S, Winter-de Groot Kd, Vreede Id, Jöbsis Q, Dompeling E. Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function. Sci Rep. 2017 Sep 27; 7(1):12350. doi: 10.1038/s41598-017-10945-3.
  10. Nielsen KG, Pressler T, Klug B, Koch C, Bisgaard H. Serial lung function and responsiveness in cystic fibrosis during early childhood. Am J Respir Crit Care Med. 2004; 169(11):1209-16.
  11. Topalovic M, Derom E, Osadnik CR, Troosters T, Decramer M, Janssens W, Belgian Pulmonary Function Study Investigators. Airways resistance and specific conductance for the diagnosis of obstructive airways diseases. Respir Res. 2015; 16(1): 88.
  12. Pittman JE1, Johnson RC, Davis SD. Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. Pediatr Pulmonol. 2012 May; 47(5):441-6. doi: 10.1002/ppul.21575. Epub 2011 Oct 18.
  13. Nicholson TT, Barry PJ, Waterhouse DF, Nolan GM, McKone EF, Gallagher CG. Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis. Respirology. 2017 Jan; 22(1):141-148. doi: 10.1111/resp.12885. Epub 2016 Sep 11.
  14. Godfrey S, Mearns M. Pulmonary function and response to exercise in cystic fibrosis. Arch. Dis. Child. 1971; 46: 144–51.
  15. Werkman MS, Hulzebos HJ, Arets HG, van der Net J, Helders PJ, Takken T. Is static hyperinflation a limiting factor during exercise in adolescents with cystic fibrosis? Pediatr. Pulmonol. 2011; 46: 119–24.
  16. Briggs EC, Nguyen T, Wall MC and MacDonald KD. Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience. Clin Respir J 2012; 6: 56–64.